Company Filing History:
Years Active: 1988
Title: Hye-Ja Oh: Innovator in Selective Dopamine Receptor Binding Agents
Introduction
Hye-Ja Oh is a notable inventor based in Cheltenham, PA (US). She has made significant contributions to the field of pharmacology, particularly in the development of selective dopamine receptor site binding agents. Her work has implications for various therapeutic applications.
Latest Patents
Hye-Ja Oh holds a patent for her invention titled "2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines." This patent describes compounds that serve as selective dopamine receptor site binding agents, which can be crucial in the treatment of neurological disorders.
Career Highlights
Throughout her career, Hye-Ja Oh has been associated with SmithKline Beecham Corporation, where she has contributed to innovative research and development projects. Her expertise in pharmacology and chemistry has positioned her as a valuable asset in her field.
Collaborations
Hye-Ja Oh has worked alongside esteemed colleagues such as Carl Kaiser and Joseph Weinstock. Their collaborative efforts have further advanced the research and development of new therapeutic agents.
Conclusion
Hye-Ja Oh's contributions to the field of pharmacology through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to influence the development of new treatments for neurological conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.